Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
TER
0,30% p.a.
Distributiebeleid
Accumulerend
Replicatie
Fysiek
Fondsgrootte
EUR 13 m
Startdatum
12 juli 2022
Bedrijven
99
Overzicht
Beschrijving
The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C seeks to track the MSCI ACWI IMI Genomic Innovation Select Screened 100 index. The MSCI ACWI IMI Genomic Innovation Select Screened 100 index tracks stocks from developed and emerging countries worldwide. The index selects companies that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance). The parent index is the MSCI ACWI IMI.
Grafiek
Basis
Data
| Beleggingsaanpak | Langdurig |
| Index | MSCI ACWI IMI Genomic Innovation Select Screened 100 |
| Investeringsfocus | Aandelen, Wereld, Gezondheidszorg, Sociaal/Milieu |
| Fondsgrootte | EUR 13 m |
| Totale kostenratio (TER) | 0,30% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Duurzaamheid | Yes |
| Valuta van het fonds | USD |
| Valuta-afgedekt | No |
| Startdatum/Noteringsdatum | 12 juli 2022 |
| Distributiebeleid | Accumulerend |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | Xtrackers |
Belastingstatus
| Duitsland | 30% belastingvermindering |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Italië | 26,0% |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | State Street Custodial Services (Ireland) Limited |
| Beleggingsadviseur | DWS Investments UK Limited |
| Bewaarbank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revisiebedrijf | Pricewaterhouse Coopers |
| Einde belastingjaar | 31 december |
| Vertegenwoordiger van Zwitserland | DWS CH AG |
| Zwitserse uitbetalende instantie | Deutsche Bank (Suisse) SA |
| Indextype | - |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | Yes |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Top 10 holdings
Weging van top 10-holdings
van 99
46,46%
| Illumina, Inc. | 5,83% |
| Natera | 5,57% |
| Moderna | 4,97% |
| Agilent Technologies | 4,96% |
| Danaher Corp. | 4,72% |
| Lonza Group AG | 4,27% |
| Vertex Pharmaceuticals | 4,20% |
| GSK PLC ADR | 4,13% |
| Roche Holding AG | 3,93% |
| Guardant Health | 3,88% |
Landen
| Verenigde Staten | 67,82% |
| Zwitserland | 12,59% |
| China | 6,09% |
| Verenigd Koninkrijk | 5,72% |
| Anders | 7,78% |
Sectoren
| Gezondheidszorg | 100,00% |
Vanaf 29/09/2026
Prestaties
Rendementsoverzicht
| YTD | +33,66% |
| 1 maand | +1,13% |
| 3 maanden | +18,31% |
| 6 maanden | +40,14% |
| 1 jaar | +37,01% |
| 3 jaar | +61,54% |
| 5 jaar | - |
| Since inception | +20,82% |
| 2025 | +5,48% |
| 2024 | +3,95% |
| 2023 | -7,06% |
| 2022 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Risico-indicator |
Lager risico Hoger risico |
| Volatiliteit 1 jaar | 23,11% |
| Volatiliteit 3 jaar | 20,18% |
| Volatiliteit 5 jaar | - |
| Rendement / Risico 1 jaar | 1,60 |
| Rendement / Risico 3 jaar | 0,86 |
| Rendement / Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -14,55% |
| Maximaal waardedaling 3 jaar | -25,40% |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -35,94% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XGEN | - - | - - | - |
| Borsa Italiana | EUR | XGEN | XGEN IM XGENEUIV | XGEN.MI XGENEURINAV=SOLA | |
| London Stock Exchange | USD | XGEN | XGEN LN XGENUSIV | XGEN.L XGENUSDINAV=SOLA | |
| London Stock Exchange | GBP | XGES | XGES LN XGENCHIV | XGES.L XGENCHFINAV=SOLA | |
| Xetra | EUR | XGEN | XGEN GY | XGEN.DE |
Meer informatie
Nieuwste artikelen
Veelgestelde vragen
What is the name of XGEN?
The name of XGEN is Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
What is the ticker of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The primary ticker of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is XGEN.
What is the ISIN of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The ISIN of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is IE000KD0BZ68.
What are the costs of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The total expense ratio (TER) of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C amounts to 0,30% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C paying dividends?
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The fund size of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is 13m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.